Loading the Newsroom

A double neural bypass in 2023 kept movement and touch gains going for about three months unplugged, raising hopes for lasting recovery.

A new approach targets saxitoxin at its source in shellfish, aiming to break the paralysis cycle that regulators and markets dread.